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An association has been reported between Wiskott-Aldrich syndrome and necrotizing vasculitis and aneurysmal arterial
dilatation. We present here the ﬁrst endovascular repair of descending thoracic aortic aneurysm in a 35-year-old male
patient with the classical Wiskott-Aldrich syndrome phenotype. He had a successful endovascular repair with early
discharge from hospital with no postoperative complications. His 1-year follow-up computed tomography scan conﬁrmed
appropriate stent position, aneurysm sac resolution with no evidence of endoleak, and no further aneurysm
formation. (J Vasc Surg 2013;58:1385-7.)Wiskott-Aldrich syndrome (WAS) is an X-linked reces-
sive disorder characterised by immunodeﬁciency, micro-
thrombocytopenia, and eczema. It is associated with an
increased incidence of autoimmune manifestation and
malignancies.1 The estimated incidence ofWAS is four cases
per million live male births.2 An association has been re-
ported between WAS and necrotizing vasculitis and aneu-
rysmal dilatation of small- and medium-size arteries.3
Currently, 10 cases of aortic aneurysm have been reported
in patients with WAS; six patients have had open aneurysm
repair. We present here the ﬁrst endovascular repair of
descending thoracic aortic aneurysm in WAS patients.
CASE REPORT
A 35-year-old male was under regular surveillance by the
Clinical-Immunology Department for WAS since childhood. He
had a history of recurrent respiratory tract and ear infections. He
also suffered from attacks of eczematous skin lesions, persistent
viral warts, and recurrent herpes-simplex reactivation (Ramsey-
Hunt syndrome). He had received platelet transfusions 6 years
ago for spontaneous bleeding from the ear secondary to micro-
thrombocytopenia. In the same year, he underwent a thoraco-
abdominal radiocontrast computed tomography (CT) scan forthe Department of Vascular Surgery,a the Department of Radiology,b
d the Department of Clinical Immunology,c Freeman’s Hospital.
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showed multiple enlarged para-aortic lymph nodes of maximum
diameter 16 mm with slight splenomegaly. Additionally, this
scan revealed mural calciﬁcations of the aortic wall, which was
unusual for his age. Follow-up CT scan was carried out 5 months
and then 2 years later (April 2006) for recurrence of his lower
abdominal symptoms and for surveillance of his para-aortic lymph
nodes, both of which conﬁrmed no change from the previous CT
scan ﬁndings. He was offered stem cell transplant. However, he
was not keen for matched unrelated transplant.
He presented again in February 2010 with recurrence of RIF
pain and chest discomfort. A CT scan of chest and abdomen
showed no change in the features of the RIF compared with his
previous scans, while the radiolabelled white-cell scan observed
a slight increase in uptake. However, this last CT scan revealed
a 55-mm descending thoracic aortic aneurysm (Fig 1). He was
offered open versus endovascular repair of this aneurysm. Following
multidisciplinary discussions, the patient preferred endovascular
stenting of the aneurysm, which was performed in June 2010.
Preoperatively, he had a hemoglobin level of 13 gdL, white
blood cell count 5.6 x 109/L, platelets count 19.0 x 109/L, and
a normal echocardiogram. He received a 1-unit platelet transfusion
during the induction of general anesthesia and the second unit
intraoperatively. He had an antibiotic cover with gentamicin 240
mg and clindamycin 600 mg.
A percutaneous left femoral artery puncture was performed,
and a 5-F gauge sheath was inserted. An intraoperative angiogram
conﬁrmed the location of the aneurysm, which was 23 cm in
length, extended from just distal to the left subclavian artery
(36-mm diameter) to 1 cm proximal to the celiac trunk (30-mm
diameter). On the right common femoral artery, a percutaneous
technique was used employing the Prostar device (Abbott Lab
Ltd, Maidenhead, Berkshire, England). An overlapping three
components of Valiant stent graft (Medtronic, Minneapolis,1385
Fig 1. Preoperative computed tomography (CT) scan, angled sagittal multiplanar reconstruction image showing
descending thoracic aortic aneurysm with calciﬁed aortic wall.
Fig 2. One-year postoperative computed tomogrpahy (CT) scan
angled sagittal multiplanar reconstruction image of the descending
thoracic aorta, showing aortic sac resolution.
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subclavian artery to just proximal to the celiac trunk. Stents were
10% oversized proximally and distally. Completion angiography
demonstrated exclusion of the aneurysm and with no endoleak.
The right femoral artery puncture was closed using the Prostar
suture, while the left femoral artery puncture was closed with the
Starclose device (Abbott Lab Ltd).
Postoperatively in the ward, he experienced mild epistaxis,
which settled spontaneously. However, he had chest pain 36 hours
postoperatively; electrocardiogram and troponin levels were within
normal. CT scan of the aorta conﬁrmed the thoracic stent was in
the correct position with patent visceral branches and no endoleak.
He was discharged at the third postoperative day.
On review at outpatient clinic 6 weeks postoperatively, he was
asymptomatic apart from occasional central chest pain not related
to exertion. Magnetic resonance imaging (MRI) conﬁrmed appro-
priate stent position with no endoleak and no further aneurysm
formation. At 1-year CT scan (Fig 2) and 2-year MRI scan
(Fig 3) follow-up, the endograft continues to function well, and
there was aneurysm sac resolution with no evidence of endoleak
or other complication. He was put under yearly surveillance with
MRI.
DISCUSSION
Our patient presented with the classical WAS pheno-
type. The most common causes of mortality among these
patients are infection (59%) followed by bleeding (27%).2
However, as there has been a signiﬁcant improvement in
the survival rate since the late 1960s, this is likely to result
in an increase of WAS patients presenting with aneurysmal
and lymphoproliﬁrative disease.2 In fact, ﬁve out of the sixWAS cases reported who were operated on for aortic aneu-
rysms were between 16 and 33 years of age.4-9
Our patient developed a 55-mm thoracic aortic aneu-
rysm in the span of less than 4 years, suggesting an acceler-
ated course. The etiology of vasculitis and the aneurysm
formation in WAS is not yet understood. McCluggage
et al reported multiple visceral arterial aneurysms in a 24-
year-old patient with WAS.3 The histopathological exami-
nation of the renal vessels of this patient showed necrotizing
Fig 3. Magnetic resonance imaging (MRI) scan at 2 years post-
operatively showing aneurysm sac resolution with no evidence of
endoleak.
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ated with marked destruction of their elastic ﬁbers. Simi-
larly, the histopathology of the ascending aneurysmal
aorta in a patient with WAS revealed chronic aortitis and
a marked destruction of the elastic ﬁbers of the aortic wall.6
In our patient, the CT showed mural calciﬁcation of
the aortic wall prior to the development of the aortic aneu-
rysm. Calciﬁed plaques have been demonstrated in WAS
patients with chronic aortitis and aortic aneurysm.4,9 The
above observations suggest the requirement for aortic
surveillance in WAS patients with aortic calciﬁcation in
order to ensure early diagnosis of aneurysmal changes.
The natural history and etiology of aneurysm formation
in WAS patients are not known. Therefore, long-term
immunosuppressive treatment would be controversial,
and it is likely to increase risk of infections as well as lym-
phoproliferative complications.10
Our patient was offered surgical treatment of his
descending thoracic aortic aneurysm based on the rapid
increase in size of his aorta, reaching 55 mm in less than
a 4-year period. The endovascular option was considered
as a safer alternative to open repair because it avoided the
thoracoabdominal incision with its associated respiratory
morbidity in this patient, who has a higher risk of respira-
tory infection. The other major challenge of open surgery
in this patient would have been the risk of considerable
blood loss secondary to thrombocytopenia, aortitis and
calciﬁcation of the aortic wall, and suture hole bleeding.8
Endovascular repair of descending thoracic aortic aneurysm
has been shown to reduce mortality and morbidity
compared with open repair.11However, the aortitis in WAS has been observed to
involve normal-diameter aorta distal to the aneurysmal
segment.5 The other ﬁnding is that aneurysm formation
in WAS appears to be progressive and could involve
more than one part of the aorta simultaneously or sequen-
tially.4,5,7,8 These two ﬁndings could obviate the endovas-
cular repair because the device would be anchored in
a diseased aortic wall. Nevertheless, the suturing of
Dacron graft in open repair to a diseased aortic wall also
carries the risk of development of false aneurysm. The
latter has been reported 8 years following open ascending
aortic repair.12
Bearing in mind the diffuse nature of vasculitis and
aneurysmal formation in these patients with WAS, it would
mandate regular lifelong surveillance of the entire aorta.
The fact that the Valiant stent is compatible with MRI
scanning makes yearly MRI surveillance of this young
group of patients with WAS following endovascular repair
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